Conclusion
The results of this study suggest that premedication with dexamethasone
has a protective effect against IRRs caused by trastuzumab in breast
cancer treatment. Future studies are needed to determine the optimal
dosing of dexamethasone to prevent IRRs and the impact of dexamethasone
on the efficacy of trastuzumab treatment.